Thrilled to share my article on percutaneous treatments for severe tricuspid regurgitation, featuring T-TEER with TriClip & Evoque valve replacement, published in Annales de Cardiologie et d'Angéiologie. #TTEER#TTVR
https://t.co/M6ZcDTqoGU
Honored to attend #EuroPCR 2025 an inspiring blend of innovation, learning & collaboration in interventional cardiology.
Grateful to present my complex case & engage with experts. Excited to apply new insights & stay connected with this amazing community!
@PCRonline
@durov Funny because both candidates are conservative. It's just that one of them is pro Russia and the other is not. I used to think that it is precisely because of your darling president that you are on the run but It seems that things have chaged a bit lately.
@RERB À quoi bon inciter les gens à prendre les transports en commun si c'est pour ensuite provoquer ce genre de perturbations ? J'espère que la prochaine fois que vous aurez besoin d'un médecin il n'y en aura qu'un sur deux qui sera allé travailler.
A #EuroPCR image 🖼️ is worth a 1,000 words:
Participate in the quiz: what pathological finding - impacting the procedure- can be concluded from this cardiac CT combined with the #3D reconstruction of the 🫀?
🔗https://t.co/MVCJ90kBaN
Image submitted by Andrei Georgian Florescu and Antoinette Neylon.
#imagefirst #YesCCT
Woke up to some really good news 🎉
My two submissions for #EuroPCR were accepted and I’m thrilled to have the opportunity to be a #PCRPresenter at one of the most important and prestigious PCI congresses in the world 🌍✨
Excited to share my work and learn from the best @PCR
✨ Welcome to our new #cardiology fellows and intern✨
Drs. G. Derquennes, C. Acatrinei, M. Mannessier, K. Tchuem, O. Bouchot, K. Garman, R. Mager, A. Florescu, L. Esposito, N. Liccardo, M. Boiago, I. Skalidis, and C. Regragui.
Best of luck to each of you on this new journey!
✨ Welcome to our new #cardiology fellows and intern✨
Drs. G. Derquennes, C. Acatrinei, M. Mannessier, K. Tchuem, O. Bouchot, K. Garman, R. Mager, A. Florescu, L. Esposito, N. Liccardo, M. Boiago, I. Skalidis, and C. Regragui.
Best of luck to each of you on this new journey!
@argulian It is impossible (and dangerous) to assume that before performing a coronary angiogram, one day one of these stress cardiomyopathies will turn out to be a proximal occluded LAD.
The RV free wall cannot be evaluated in this video and longitudinal function seems preserved.
Breaking — if true, this is massive news.
#OCEANIC-AF trial of oral Factor XI inhibitor vs Apixaban in pts w #afib being stopped early for inferiority. (We had just started randomizing recently) 👇🏻 cc @kaulcsmc #EPeeps https://t.co/iq3cyEXN5R
@drevanyates @smithECGBlog There's no such thing as 90% occlusion, the artery is either occluded or not, from what you're saying this patient had coronary stenosis